Suppr超能文献

由H3K4甲基转移酶MLL4介导的增强子预激发控制细胞命运转变。

Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

作者信息

Wang Chaochen, Lee Ji-Eun, Lai Binbin, Macfarlan Todd S, Xu Shiliyang, Zhuang Lenan, Liu Chengyu, Peng Weiqun, Ge Kai

机构信息

Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.

Division of Developmental Biology, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.

出版信息

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11871-11876. doi: 10.1073/pnas.1606857113. Epub 2016 Oct 3.

Abstract

Transcriptional enhancers control cell-type-specific gene expression. Primed enhancers are marked by histone H3 lysine 4 (H3K4) mono/di-methylation (H3K4me1/2). Active enhancers are further marked by H3K27 acetylation (H3K27ac). Mixed-lineage leukemia 4 (MLL4/KMT2D) is a major enhancer H3K4me1/2 methyltransferase with functional redundancy with MLL3 (KMT2C). However, its role in cell fate maintenance and transition is poorly understood. Here, we show in mouse embryonic stem cells (ESCs) that MLL4 associates with, but is surprisingly dispensable for the maintenance of, active enhancers of cell-identity genes. As a result, MLL4 is dispensable for cell-identity gene expression and self-renewal in ESCs. In contrast, MLL4 is required for enhancer-binding of H3K27 acetyltransferase p300, enhancer activation, and induction of cell-identity genes during ESC differentiation. MLL4 protein, rather than MLL4-mediated H3K4 methylation, controls p300 recruitment to enhancers. We also show that, in somatic cells, MLL4 is dispensable for maintaining cell identity but essential for reprogramming into induced pluripotent stem cells. These results indicate that, although enhancer priming by MLL4 is dispensable for cell-identity maintenance, it controls cell fate transition by orchestrating p300-mediated enhancer activation.

摘要

转录增强子控制细胞类型特异性基因表达。起始增强子以组蛋白H3赖氨酸4(H3K4)单/二甲基化(H3K4me1/2)为标记。活性增强子进一步以H3K27乙酰化(H3K27ac)为标记。混合谱系白血病4(MLL4/KMT2D)是一种主要的增强子H3K4me1/2甲基转移酶,与MLL3(KMT2C)具有功能冗余。然而,其在细胞命运维持和转变中的作用仍知之甚少。在这里,我们在小鼠胚胎干细胞(ESC)中发现,MLL4与细胞身份基因的活性增强子相关联,但令人惊讶的是,它对于这些增强子的维持是可有可无的。因此,MLL4对于ESC中细胞身份基因的表达和自我更新是可有可无的。相比之下,在ESC分化过程中,MLL4是H3K27乙酰转移酶p300与增强子结合、增强子激活以及细胞身份基因诱导所必需的。MLL4蛋白而非MLL4介导的H3K4甲基化控制p300募集到增强子。我们还表明,在体细胞中,MLL4对于维持细胞身份是可有可无的,但对于重编程为诱导多能干细胞是必不可少的。这些结果表明,尽管MLL4介导的增强子起始对于细胞身份维持是可有可无的,但它通过协调p300介导的增强子激活来控制细胞命运转变。

相似文献

1
4
H3K4 Methyltransferase Activity Is Required for MLL4 Protein Stability.MLL4蛋白稳定性需要H3K4甲基转移酶活性。
J Mol Biol. 2017 Jun 30;429(13):2046-2054. doi: 10.1016/j.jmb.2016.12.016. Epub 2016 Dec 21.

引用本文的文献

本文引用的文献

2
The selection and function of cell type-specific enhancers.细胞类型特异性增强子的选择与功能。
Nat Rev Mol Cell Biol. 2015 Mar;16(3):144-54. doi: 10.1038/nrm3949. Epub 2015 Feb 4.
5
Enhancer RNAs and regulated transcriptional programs.增强子RNA与调控转录程序
Trends Biochem Sci. 2014 Apr;39(4):170-82. doi: 10.1016/j.tibs.2014.02.007. Epub 2014 Mar 24.
8
Super-enhancers in the control of cell identity and disease.超级增强子在细胞身份和疾病中的调控作用。
Cell. 2013 Nov 7;155(4):934-47. doi: 10.1016/j.cell.2013.09.053. Epub 2013 Oct 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验